DR. JEFFREY CUMMINGS, world leader in Alzheimer’s research, will deliver the DISTINGUISHED NEUROSCIENCE LECTURE
Dr. Cummings, Director of the Cleveland Lou Ruvo Center for Brain Research, will deliver a research lecture at 12:00, Thursday, October 13th entitled “Alzheimer’s Drug Development: Challenges and Promises”. On Thursday evening at 7 PM he will deliver a public lecture: “Alzheimer’s Disease: Advances in understanding and treatment”
Dr. Cummings received his undergraduate degree from the University of Wyoming and received his M.D. from the University of Washington. He did his residency in Neurology at Boston University. He received additional training in Neuropathology and Neuropsychiatry at the National Hospital for Nervous Diseases in Queen Square, England.
Dr. Cummings has authored more than 500 peer-reviewed papers and 30 books on Alzheimer’s disease, neuropsychiatry, and clinical trials. Dr. Jeffrey Cummings is a member of the Alzheimer’s Disease Cooperative Study (ADCS), the NINDS Neuroprotection in Parkinson’s Disease (NET-PD) oversight committee, American College of Neuropsychopharmacology, American Society for Experimental Neurotherapeutics, American Academy of Neurology, American Neurologic Association, American Neuropsychiatric Association (past president), Behavioral Neurology Society (past president), and American Association of Geriatric Psychiatry (honorary member), among many prestigious organizations. He is the author of the Neuropsychiatric Inventory (NPI). This outcome measurement tool identifies behavioral features that are common in dementias and is used world-wide in clinical trials to assess the efficacy of anti-dementia agents.